Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma
Stopped PI stated trial no longer fits the framework \& portfolio of work that is prioritized by the department. PI will not have the anticipated accrual in PI view to complete the study. Given that, PI request this protocol be closed prior to its activation.
Conditions
- Metastatic Ewing Sarcoma
- Recurrent Ewing Sarcoma
Interventions
- PROCEDURE: Fine-Needle Aspiration
- DRUG: Irinotecan
- DRUG: Irinotecan Hydrochloride
- DRUG: Lurbinectedin
Sponsor
M.D. Anderson Cancer Center
Collaborators